Gingivitis inducida por biopelícula dental y enfermedades gingivales no inducidas por biopelícula dental

The objective of this review is to know the scientific evidences that allow to establish the bases of the changes applied to the classification of the diseases and conditions that affect the periodontium of protection so that the diagnosis is based on the definition of cases. The information provided provides useful diagnostic, prevention, therapeutic and epidemiological strategies for clinicians and researchers in order to diagnose and properly manage the patient. Common clinical features of gingival conditions induced by biofilm include: a) clinical signs and symptoms of inflammation limited to the gum, b) reversibility of inflammation by removing or altering the biofilm, c) presence of a high biofilm load bacterial to initiate inflammation; d) modifying factors that can alter the severity of inflammation and e) stable levels of insertion, over a periodontium that may or may not have a history of insertion loss or alveolar bone. The simplified taxonomy of gingival conditions includes: 1) introduction of the term “incipient gingivitis”; 2) description of the extent and severity of gingival inflammation; 3) description of the extent and severity of gingival enlargement; 4) reduction of the categories of taxonomy of plaque-induced gingival disease; 5) use of the term necrotizing diseases to encompass gingivitis, periodontitis and stomatitis necrotizing, 6) consideration of linear erythema as oral candidiasis; 7) creation of a more complete nomenclature of pathologies related to non-biofilm-induced diseases that includes the International Code of Diseases ICD-10. In conclusion, biofilm-induced gingivitis is classified by site, in an intact periodontium and in a reduced periodontium. According to its extension, it is classified as localized with SS =10% and =30%, without insertion loss or radiographic bone loss and generalized with SS> 30%, without insertion loss or radiographic bone loss. In the periodontium the first signs of undiagnosed systemic diseases and conditions can be reflected, as well as oral manifestations of some pathologies. Biofilm control in systemic patients is essential to prevent complications.